Carcinoembryonic antigen (CEA) and tissue polypeptide antigen (TPA) in the diagnosis of small cell and non-small cell bronchial cancer
Schultek, T.; Wiessmann, K.J.; Braun, J.; Wenzel, B.; Wood, W.G.
Praxis und Klinik der Pneumologie 39(12): 962-966
1985
ISSN/ISBN: 0342-7498 PMID: 3006012 Document Number: 249402
Document emailed within 1 workday
Related Documents
Salvati, F.; Antilli, A.; Cruciani, A.R.; Pau, F.; Flore, F.; Munno, R.; De Angelis, G.; Cipri, A.; Pigorini, F. 1985: Plasma carcinoembryonic antigen and tissue polypeptide antigen levels in lung cancer: correlation with cell types and stage Cancer Detection and Prevention 8(1-2): 111-114Hino, M.; Ogasawara, H.; Yoshii, A.; Yoneda, S.; Noguchi, Y.; Sakai, H.; Yoshida, K. 1992: Clinical significance of serum carcinoembryonic antigen in small cell lung cancer patients Nihon Kyobu Shikkan Gakkai Zasshi 30(2): 278-284
Björklund, V.; Björklund, B. 1983: Differential immunocytochemical localization of tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) in breast cancer Cancer Detection and Prevention 6(1-2): 193-198
Chantapet, P.; Riantawan, P.; Lebnak, P.; Getngern, P. 2000: Utility of serum cytokeratin 19 fragment (CYFRA 21-1) and carcinoembryonic antigen (CEA) as tumour markers for non-small cell lung cancer Journal of the Medical Association of Thailand 83(4): 383-391
Graziano, S.L.; Tatum, A.H.; Newman, N.B.; Oler, A.; Kohman, L.J.; Veit, L.J.; Gamble, G.P.; Coleman, M.J.; Barmada, S.; O'Lear, S. 1994: The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage i and Ii non-small cell lung cancer Cancer Research 54(11): 2908-2913
Hung, Y.C.; Shiau, Y.C.; Chang, W.C.; Kao, C.H.; Lin, C.C. 2002: Early predicting recurrent cervical cancer with combination of tissue polypeptide specific antigen (TPS) and squamous cell carcinoma antigen (SCC) Neoplasma 49(6): 415-417
Xu, C.-a.; Su, H.; Liu, J.-l.; Li, L.; Zou, H.-w. 2011: Value of serum carcinoembryonic antigen in prediction of chemotherapy efficacy and prognosis in patients with advanced non-small cell lung cancer treated with EGFR-tyrosine kinase inhibitor Zhonghua Zhong Liu Za Zhi 33(6): 436-441
Michetti, G.; Bamberga, M.; Pugliese, C.; Ori Belometti, M.; Arnone, P.; Minio, A.; Ciaravino, G.; Villa, R.; Alesina, R.; Cottini, M. 1994: The importance of measuring plasma carcinoembryonic antigen in small-cell anaplastic carcinoma Minerva Medica 85(5): 231-236
Jin, B.; Zhang, Y.; Zhang, X.; Li, R.; Lou, Y.; Niu, Y.; Huang, A.; Han, B. 2014: Value of carcinoembryonic antigen levels in predicting the efficacy of EGFR-TKi in advanced non-small cell lung cancer harboring EGFR mutations Zhonghua Yi Xue Za Zhi 94(30): 2327-2331
Ishiwata, N.; Jinn, Y.; Tsukada, Y.; Inase, N.; Ichioka, M.; Yoshizawa, Y. 2000: Relationship between apoptosis and immunohistochemical staining for proliferating cell nuclear antigen and Ki-67 in non-small cell lung cancer Anticancer Research 20(3a): 1445-1450
Mourtzikou, A.; Stamouli, M.; Kroupis, C.; Christodoulou, S.; Skondra, M.; Kastania, A.; Pectasides, D.; Athanasas, G.; Dimas, C. 2012: Evaluation of Carcinoembryonic Antigen (CEA), Epidermal Growth Factor Receptor (EGFR), Epithelial Cell Adhesion Molecule EpCAM (GA733-2), and Carbohydrate Antigen 19-9 (CA 19-9) Levels in Colorectal Cancer Patients and Correlation with Clinicopathological Characteristics Clinical Laboratory 58(5-6): 441-448
Okishio, K.; Kudoh, S.; Katsumoto, E.; Ohtsuka, T.; Shoji, S.; Fujii, T.; Kanazawa, H.; Hirata, K.; Kurihara, N.; Yoshikawa, J. 1996: Small-cell lung cancer and subacute sensory neuropathy in a patient positive for the anti-Hu antigen Nihon Kyobu Shikkan Gakkai Zasshi 34(7): 816-821
Sujino, H.; Nagamori, S.; Fujise, K.; Hasumura, S.; Homma, S.; Matsuura, T.; Shimizu, K.; Niiya, M.; Kameda, H. 1988: Establishment and characterization of human pancreatic adenocarcinoma cell line JHP-1 producing carbohydrate antigen 19-9 and carcinoembryonic antigen Human Cell 1(2): 250-255
Bando, T.; Fujimura, M.; Kasahara, K.; Matsuda, T. 1998: Significance of Na+, K(+)-ATPase on intracellular accumulation of cis-diamminedichloroplatinum(II) in human non-small-cell but not in small-cell lung cancer cell lines Anticancer Research 18(2a): 1085-1089
Kozielski, J. 1983: Carcinoembryonic antigen in bronchial cancer Pneumonologia Polska 51(6): 361-365
Alekseenko, O.I. 2004: Cytogenetic features of the differential diagnosis of lymphoid thymomas, small-cell non-Hodgkin lymphomas and undifferentiated small cell lung carcinoma Tsitologiia i Genetika 38(2): 51-54
Doyle, L.A.; Cuttitta, F.; Mulshine, J.L.; Bunn, P.A.; Minna, J.D. 1987: Markedly different antibody responses to immunized small cell and non-small cell lung cancer cells Cancer Research 47(19): 5009-5013
Schalhorn, A. 1985: Bronchial cancer: possibilities and limits of chemotherapy. 2: Non-small cell bronchial cancer Fortschritte der Medizin 103(17): 453-456
Neill, H.B.; Miller, A.A.; Clamon, G.H.; Perry, M.C.; Crawford, J.; Green, M.R. 1997: A phase Ii study evaluating the efficacy of carboplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in patients with stage IIIB and IV non-small cell lung cancer and extensive small cell lung cancer Seminars in Oncology 24(4 Suppl 12: S12
Johnson, D.H. 1990: Overview of ifosfamide in small cell and non-small cell lung cancer Seminars in Oncology 17(2 Suppl 4: 24-30